Celltrion
068270.KS
#808
Rank
ยฃ21.52 B
Marketcap
ยฃ95.69
Share price
2.24%
Change (1 day)
8.79%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2025 (TTM): ยฃ0.42 Billion

According to Celltrion 's latest financial reports the company's current earnings are ยฃ2.68 Billion. In 2024 the company made an earning of ยฃ0.35 Billion a decrease over its 2023 earnings that were of ยฃ0.38 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.42 B20.47%
2024 ยฃ0.35 B-8.89%
2023 ยฃ0.38 B6.61%
2022 ยฃ0.36 B-21.93%
2021 ยฃ0.46 B10.28%
2020 ยฃ0.41 B65.38%
2019 ยฃ0.25 B16.74%
2018 ยฃ0.21 B-33.93%
2017 ยฃ0.32 B106.65%
2016 ยฃ0.15 B25.18%
2015 ยฃ0.12 B-6.4%
2014 ยฃ0.13 B47.49%
2013 ยฃ91.93 M-33.58%
2012 ยฃ0.13 B
2010 ยฃ72.03 M72.52%
2009 ยฃ41.75 M258.3%
2008 ยฃ11.65 M